title: Quantification of neurotrophin mRNA expression in PMN mouse: modulation by xaliproden.
abstract: Compounds possessing neurotrophic properties may represent a possible treatment for neurodegenerative disorders such as amyotrophic lateral sclerosis. Xaliproden (SR57746A), an orally-active non-peptide compound, which has been found to exhibit neurotrophic effects in vitro and in vivo, increased the lifespan and delayed the progression of the motor neuron degeneration in PMN mice. We have used a quantitative reverse transcription/polymerase chain reaction amplification technique to study the regulation of neurotrophin mRNA and trk mRNA expression in PMN mice. NGF and NT-3 mRNA are downregulated in PMN mice. These deficiencies can be overcome by a treatment with xaliproden. Such an effect could contribute to neurotrophic effects of xaliproden in vivo and in vitro.
authors.affiliation: University Louis Pasteur, Pharmacology Faculty, Illkirch Cedex, France.
authors.forename: A
authors.initials: A
authors.lastname: Appert-Collin
authors.forename: F H T
authors.initials: FH
authors.lastname: Duong
authors.forename: P
authors.initials: P
authors.lastname: Passilly-Degrace
authors.forename: J-P
authors.initials: JP
authors.lastname: Gies
authors.forename: J-M
authors.initials: JM
authors.lastname: Warter
authors.forename: P
authors.initials: P
authors.lastname: Poindron
mesh_terms: D000818:Animals; D001923:Brain Chemistry / Q000235:genetics; D019208:Brain-Derived Neurotrophic Factor / Q000096:biosynthesis; D017931:DNA Primers; D005260:Female; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000378:metabolism; D008297:Male; D051379:Mice; D009281:Naphthalenes / Q000494:pharmacology*; D020932:Nerve Growth Factor / Q000096:biosynthesis / Q000187:drug effects; D009414:Nerve Growth Factors / Q000096:biosynthesis* / Q000235:genetics; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000378:metabolism*; D020933:Neurotrophin 3 / Q000096:biosynthesis / Q000235:genetics; D011725:Pyridines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D020917:Receptor, trkA / Q000096:biosynthesis / Q000235:genetics; D020812:Receptor, trkC / Q000096:biosynthesis / Q000187:drug effects; D017475:Receptors, Nerve Growth Factor / Q000096:biosynthesis / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013116:Spinal Cord / Q000378:metabolism
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D017931:DNA Primers; D009281:Naphthalenes; D009414:Nerve Growth Factors; D020933:Neurotrophin 3; D011725:Pyridines; D012333:RNA, Messenger; D017475:Receptors, Nerve Growth Factor; D020932:Nerve Growth Factor; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D020917:Receptor, trkA; D020812:Receptor, trkC; C462299:xaliproden